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Background: In view of the global increase in diabetes, and the fact that recent findings indicate that diabetic
neuropathy is more frequently seen in males, it is crucial to evaluate any gender differences in nerve regeneration
in diabetes. Our aim was to evaluate in short-term experiments gender dissimilarities in axonal outgrowth in healthy
and in genetically developed type 2 diabetic Goto-Kakizaki (GK) rats, and also to investigate the connection
between activated (i.e. ATF-3, Activating Transcription Factor 3) and apoptotic (cleaved caspase 3) Schwann cells
after sciatic nerve injury and repair. Female and male diabetic GK rats, spontaneously developing type 2 diabetes, were
compared with corresponding healthy Wistar rats. The sciatic nerve was transected and instantly repaired. After six days
the nerve was harvested to measure axonal outgrowth (i.e. neurofilament staining), and to quantify the number of
ATF-3 (i.e. activated) and cleaved caspase 3 (i.e. apoptotic) stained Schwann cells using immunohistochemistry.
Results: Axonal outgrowth was generally longer in male than in female rats and also longer in healthy than in diabetic
rats. Differences were observed in the number of activated Schwann cells both in the distal nerve segment and close
to the lesion site. In particular the female diabetic rats had a lower number. There were no gender differences in
number of cleaved caspase 3 stained Schwann cells, but rats with diabetes exhibited more (such cleaved caspase 3
stained Schwann) cells both at the lesion site and in the distal part of the sciatic nerve. Axonal outgrowth correlated
with the number of ATF3 stained Schwann cells, but not with blood glucose levels or the cleaved caspase 3 stained
Schwann cells. However, the number of cleaved caspase 3 stained Schwann cells correlated with the blood glucose
level.
Conclusions: We conclude that there are gender differences in nerve regeneration in healthy rats and in type 2
diabetic GK rats.
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Neuropathy, which is a general complication in both
type 1 and type 2 diabetes, may cause serious problems
for patients, particularly male patients with type 2 dia-
betes [1]. Male patients also seem to develop neuropathy
earlier than female patients [1,2]. The mechanisms be-
hind the development of neuropathy are complex and
not fully understood, nor why male patients express
neuronal complications earlier than female patients. The* Correspondence: Lena.Stenberg@med.lu.se
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article, unless otherwise stated.gender differences are also relevant in traumatic nerve
injuries since such injuries more frequently affect males.
Earlier studies have shown that neuroactive hormones
or steroids (affecting the nervous systems), such as testos-
terone and progesterone, play an active role in nerve re-
generation and that the levels of neuroactive steroids
differ in male and female rats, among both healthy and
diabetic rats [3-5]. Recent findings indicate that axonal
outgrowth six days after nerve injury and repair does not
differ between healthy and diabetic BB (i.e. genetically de-
veloped and resembling type 1 diabetes; [6]) (female) rats.
However, both numbers of activated and apoptotic
Schwann cells, which are present in the distal nerve seg-
ment, were significantly higher in female diabetic BB ratsCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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relation between axonal outgrowth and Schwann cell acti-
vation (i.e. ATF 3 staining) has been reported, indicating
the importance of Schwann cells for nerve regeneration
and that the time point for nerve repair is crucial for
axonal outgrowth [7-9]. Clarification of the nerve regener-
ation process from a gender perspective as well as in rela-
tion to a rat model with genetically developed diabetes
similar to type 2, in contrast to the streptozotocin-induced
diabetes model [10], is needed. This is relevant in view of
the global increase in the number of patients with type 2
diabetes, where neuropathy is often present, and the fact
that males are frequently affected by traumatic nerve injur-
ies, particularly in the upper extremity, which require nerve
repair or reconstruction. Thus, our aims were two-fold; to
investigate any gender differences in nerve regeneration
after nerve injury and repair in healthy rats from a short-
term perspective and to explore whether the process is dif-
ferent in genetically developed type 2 Goto-Kakizaki
diabetic rats. In conclusion, we observed differences be-
tween healthy and diabetic rats, using an appropriate dia-
betic animal model, as well as between male and female
rats, with interesting correlations.
Results
Fasting blood glucose and weight increase
Pre- and post-operative blood glucose levels were signifi-
cantly higher (Fisher’s method; p < 0.0001) in diabetic than
in healthy rats and were also significantly higher p < 0.0001)
in male than in female rats (Table 1). There were no statis-
tical differences between the groups concerning increase in
weight during the regeneration period (Table 1).Table 1 Nerve regeneration after nerve injury and repair in h
Healthy male Healthy female Diabetes m
(n = 10) (n = 10) (n = 10)
Axonal outgrowth
(neurofilaments, mm)
7.0 (6.8-7.3) 6.3 (6.1-6.4) 6.9 (6.7-7.1
ATF-3 (% of total) SNL 17.8 (17.6-18.4) 17.6 (16.7-18.0) 19.8 (19.1-2
ATF-3 (% of total) SND 19.2 (17.7-19.6) 19.5 (18.9-20.1) 18.7 (16.9-2
Cleaved caspase-3
(% of total) SNL
5.2 (2.6-7.8) 3.1 (2.9-3.4) 9.6 (8.7-11.
Cleaved caspase-3
(% of total) SND
2.7 (2.2-4.0) 2.5 (2.4-2.7) 6.4 (4.5-7.1
Total cell number
(mm2) SNL
1137 (1127-1142) 1050 (1027-1066) 1073 (1046
Total cell number
(mm2) SND
1137 (1122-1152) 1112 (1068-1147) 1053 (1019
Preoperative
B-glucose (mmol/l)
4.6 (4.3-4.9) 3.90 (3.8-4.3) 15.0 (13.3-1
Weight increase (%) 2.2 (0.7-2.7) 2.4 (1.3-4.8) 2.0 (1.2-2.6
Values are median 25th (Q1) -75th (Q3) percentiles. aKW = Kruskal-Wallis. bFisher’s me
SNL = Lesion site. SND = Distal nerve segment. Total cell = DAPI stained cells. P-valueLength of axonal outgrowth
Statistical differences were found between male and fe-
male rats (p < 0.0001; Fisher’s test; Table 1) with longer
outgrowth (Figure 1) in male rats (p < 0.0001 for both
healthy and diabetic rats, MW). There were also distinc-
tions between healthy and diabetic rats (p = 0.02; Fisher’s
test), where axonal outgrowth was much longer in fe-
male healthy rats than in female diabetic rats (p = 0.004,
MW, Table 1), while no difference was observed between
healthy and diabetic male rats (p = 0.68, MW).
ATF-3 stained Schwann cells at the site of lesion
Only those cells with a Schwann cell shape were counted
as ATF-3 stained Schwann cells (Figure 2a,c-d). ATF-3
stained Schwann cells differed (p = 0.0001; KW) at the le-
sion site. The Fisher’s test showed a statistical difference (p =
0.0001) between male and female rats and also between
healthy and diabetic rats (p = 0.001). The number of ATF-3
stained Schwann cells was higher (p = 0.001 MW) in dia-
betic rats than in healthy male rats. The numbers were also
higher (p = 0.0001, MW) in diabetic male rats than in dia-
betic female rats. On the contralateral side (i.e. uninjured
side), only a few ATF-3 stained Schwann cells were found.
ATF-3 stained Schwann cells in the distal nerve segment
Again, only cells with the shape of a Schwann cell were
counted as ATF-3 stained Schwann cells. ATF-3 stained
Schwann cells differed (p = 0.0001; KW) in the distal seg-
ment. The Fisher’s test demonstrated significant differences
between male and female rats (p = 0.0003) as well as be-
tween healthy and diabetic rats (p = 0.001). Higher numbers
of ATF-3 stained Schwann cells (p = 0.0001, MW) wereealthy and diabetic rats
ale Diabetes female p-values (KWa) Fisher’s methodb
(n = 10) Male/female Healthy/
Diabetes
) 5.8 (5.1-6.2) 0.0001 <0.0001 0.02
1.1) 16.4 (15.7-17.3) 0.0001 0.0001 0.001
0.1) 15.2 (14.4-15.7) 0.0001 0.0003 0.001
6) 7.0 (6.4-10.1) 0.0001 0.31 <0.0001
) 5.8 (4.3-6.1) 0.0001 0.39 <0.0001
-1103) 1089 (1059-1098) 0.0001 0.0007 0.0001
-1091) 1093 (1045-1102) 0.0001 0.07 <0.0001
7.2) 10.3 (9.7-11.7) 0.0001 <0.0001 <0.0001
) 2.6 (2.0-3.2) 0.34 - -
thod for independent samples based on the chi square distribution.
s in bold is significantly different at least at the 0.05 level.
Figure 1 Immunohistochemistry of neurofilament staining. Immunohistochemistry of staining for neurofilament proteins in female
(a) and male (b) GK rats. The arrow indicates tip of the outgrowing axons, where the nerve repairs are in the left part of the panel.
Length of bar = 1000 μm.
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rats and in healthy female rats than in diabetic female rats
(p = 0.0001, MW). Again, few ATF-3 stained Schwann
cells were found on the contralateral side.
Cleaved caspase-3 stained Schwann cells at the lesion site
Generally, there were differences (p = 0.0001; KW) regard-
ing numbers of cleaved caspase 3 stained Schwann cells at
the lesion site in the sciatic nerve (Figure 2b,e-f). There
were mostly no gender differences in the number of
cleaved caspase 3 stained Schwann cells at the lesion site
(p = 0.31, Fisher’s test) among male and female rats. How-
ever, a significant difference was found between healthy
and diabetic rats (p < 0.0001, Fisher’s test). The number ofFigure 2 Immunohistochemistry of ATF3 and cleaved caspase 3 stain
cells in Wistar (a) and GK (b) male rats as well as cleaved caspase 3 stained
staining of ATF 3 and S-100 (e) as well as cleaved caspase 3 and S-100 (f),stained cleaved caspase 3 Schwann cells was statistically
higher (p = 0.0001, MW) in diabetic male rats than in
healthy male rats and also in diabetic female rats than in
healthy female rats (p = 0.0001 MW). Single cleaved cas-
pase 3 stained Schwann cells were found on the contralat-
eral side.
Cleaved caspase 3 stained Schwann cells in the distal
nerve segment
There were generally differences (p = 0.0001; KW) regard-
ing cleaved caspase 3 stained Schwann cells in the distal
nerve segment. Furthermore, Fisher’s test showed no sig-
nificant differences between male and female rats (p = 0.39),
but a significant difference between healthy and diabeticed Schwann cells. Immunohistochemistry of ATF3 stained Schwann
cells in Wistar (c) and GK (d) male rats; all at the lesion site. Double
at the lesion site in a male GK rat. Length of bar = 100 μm.
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caspase-3 stained Schwann cells (P = 0.0001, MW) was
found in diabetic female rats than in healthy female rats.
There were also significantly higher numbers in diabetic
male rats (p = 0.0001, MW) than in healthy male rats.
Again, single cleaved caspase 3 stained Schwann cells were
found on the contralateral side.
Total number of DAPI stained cells at the lesion site
Kruskal-Wallis showed differences (p = 0.0001) with re-
spect to total number of DAPI stained cells at the lesion
site. There were significant differences in the total num-
ber of DAPI stained cells between male and female rats
(p = 0.0007, Fisher’s test; Table 1) and between healthy
and diabetic rats (p = 0.0001). The total number of DAPI
stained cells at the lesion site was higher in the healthy
male rats than in healthy female rats (p = 0.0001, MW)
and in healthy male rats than in diabetic male rats (p =
0.0001, MW).
Total number of DAPI stained cells in the distal nerve
segment
Kruskal-Wallis showed differences (p = 0.0001) in the
total number of DAPI stained cells in the distal nerve
segment. Significant differences were observed between
healthy and diabetic rats (p < 0.0001, Fisher’s test), but
not between male and female rats (p = 0.07; Fisher’s test).
There was a significantly higher number of total DAPI
stained cells in healthy male rats than in diabetic male
rats (p = 0.0001, MW).
Correlation
All rats pooled
The Spearman correlation test showed a significant posi-
tive correlation between numbers of ATF-3 stained
Schwann cells at the lesion site and axonal outgrowth
(rho = 0.59, p = 0.0001; Figure 3a), but blood glucose levels
did not correlate with axonal outgrowth (p = 0.39) when
all rats were pooled. Preoperative blood glucose level and
cleaved caspase 3 stained Schwann cells at the lesion site
were also tested for correlation and found to be positively
correlated (rho = 0.69, p = 0.0001; Figure 3b). A weaker
correlation (rho = 0.32, 0 = 0.046) was found between pre-
operative blood glucose and numbers of ATF-3 stained
Schwann cells at the lesion site. While there was no
significant correlation between the numbers of cleaved
caspase 3 stained Schwann cells and axonal outgrowth
(p = 0.24), they correlated weakly with the number of
ATF-3 stained Schwann cells (rho = 0.40, p = 0.01).
In the distal nerve segment, when all rats were pooled,
the preoperative blood glucose levels positively corre-
lated with the number of cleaved caspase 3 stained
Schwann cells (rho = 0.74, p = 0.0001, Figure 3c), but the
blood glucose levels did not correlate with the numbersof ATF 3 stained Schwann cells (p = 0.11). The weight in-
crease in the rats did not influence any of the variables.
Diabetic rats
If the diabetic animals were analysed separately, there
was a positive correlation between preoperative blood glu-
cose levels, and axonal outgrowth (rho = 0.60, p = 0.005;
Figure 3d) and ATF-3 stained Schwann cells at the site of
the lesion (rho = 0.67, p = 0.001) as well as between the
number of ATF-3 and cleaved caspase 3 stained Schwann
cells at the lesion site (rho = 0.51, p = 0.02; Figure 3e). Fur-
thermore, in the diabetic rats the preoperative blood glu-
cose levels positively correlated with the number of ATF-3
stained Schwann cells in the distal nerve segment (rho =
0.66, p = 0.001, Figure 3f).
Healthy rats
The blood glucose levels in healthy rats positively corre-
lated with axonal outgrowth (rho = 0.60, p = 0.005).
Discussion
We examined whether any gender differences between fe-
male and male rats, regarding axonal outgrowth, were
present. In particular, we analysed how a high blood glu-
cose level in a diabetic GK rat model, resembling type 2
diabetes, influenced the axonal outgrowth. The published
literature in the field of nerve regeneration in diabetes is
limited and studies almost exclusively use streptozotocin-
induced diabetes in rats in which blood glucose levels are
high (see e.g. [11-14]). The ability of axons to regenerate in
relation to the state of the Schwann cells may also be an
important point in relation to moderate blood glucose
levels and in view of the global increase of diabetes, par-
ticularly bearing in mind its most common complica-
tion, i.e. neuropathy. We used genetically developed
diabetic GK rats as a model for type 2 diabetes, which is a
valid model and also a gentle alternative to the diabetic
BB (BioBreeding) rats [6] and the frequently used rats with
streptozotocin-(STZ)induced diabetes. The similarity with
human beta cells, compared to these cells in other rodent
models, is an unique characteristic of GK rats [15] making
the model valid also for studies of the peripheral nervous
system. The relationship between ATF3 and cleaved cas-
pase 3 stained Schwann cells and axonal outgrowth were
evaluated in these rat models. The present nerve regen-
eration model utilizes the possibility of analysing ATF3
(i.e. activation) and cleaved caspase 3 (i.e. apoptosis) stained
Schwann cells in relation to axonal outgrowth, where the
cells at the lesion site (SNL) interact with the outgrowing
axons, while the axons have not yet reached the analysis
site in the distal nerve segment (SND; Figure 4; [9]).
Few studies have highlighted any gender differences or
possible mechanisms in nerve regeneration (see e.g. [16-18]).
Our results clearly show that there was a gender difference
Figure 3 Scatter plots from all rats (a-c) and rats with diabetes (d-f). Scatter plots from all rats pooled (a-c) with numbers of ATF-3 stained
cells (lesion site) and axonal outgrowth (a; rho = 0.59, p = 0.0001), preoperative blood glucose level and cleaved caspase 3 stained cells (b, lesion
site; rho = 0.69, p = 0.0001; c. in distal nerve segment; rho = 0.74, p = 0.0001). Scatter plots from diabetic rats (d-f) with preoperative blood glucose
levels and axonal outgrowth (d, rho = 0.60, p = 0.005; d), number of cleaved caspase 3 and ATF-3 stained cells (e, lesion site; rho = 0.51, p = 0.02)
and preoperative blood glucose level and number of ATF-3 stained cells (f, distal nerve segment; rho = 0.66, p = 0.001).
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Figure 4 Schematic drawing of the experimental set up. The sciatic
nerve was transected and immediately repaired. Axonal outgrowth
was evaluated by measuring the length of neurofilaments (NF). The
numbers of activated (Activating Transcription Factor 3; ATF3) and
apoptotic (cleaved caspase 3) Schwann cells were measured just distal
to the lesion site (i.e. axons presented) and in the distal nerve segment
(distal to the most distal parts of the neurofilament stained axons).
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longer outgrowth in male rats. The weight increase in the
rats, a possible factor in a difference in axonal outgrowth,
did not differ between male and female or even between
healthy and diabetic rats and did not correlate with any of
the variables; thus it could not explain the difference.
However, our results are in accordance with previous stud-
ies using a nerve crush injury, i.e. a clinically less important
injury [19], showing that neuroactive steroids, such as
pregnenolone and progesterone metabolites that interact
with progesterone receptor, are protective. This is also rele-
vant for myelin repair in different neurological disorders
[20]. Progesterone has been considered as an autocrine sig-
nalling molecule [21]. Interestingly, progesterone-loaded
chitosan prostheses have been used to successfully recon-
struct nerve injuries [22]; chitosan conduits being a prom-
ising clinical material for nerve reconstruction [23].
Potential use of neuroactive steroids, such as progesterone
and testosterone, for treatment of diabetic neuropathy has
also been suggested [5,24], where differences between gen-
der, diabetic state and a regional location, with request to
neuroactive steroid levels, are reported [3,25]. The reason
(s) male subjects with diabetes develop neuropathy earlier
than female subjects [1,2] is not clear and may be complex,
but factors such as testosterone deficiency, which is com-
mon in men with diabetes (i.e. leading to a pronounced
deficit of neurosteroids), as well as lifestyle differences may
contribute to the discrepancy in development, at least in
type 2 diabetes in humans [26]. In addition, the mecha-
nisms for the development of neuropathy in type 1 and 2
in humans may be different and particularly complex and
multifactorial in type 2 diabetes [27,28] which the present
GK rat model resembles.In our short-term model (i.e. six days), the regeneration
process, which showed longer regeneration distances in
male rats, may depend on the level of blood glucose.
Thus, a moderately higher short-term blood glucose level
may be advantageous for axons, leading to longer axonal
outgrowth, while the opposite may be present in humans
where higher long-standing blood glucose levels may have
deleterious effects on the neurons and Schwann cells. An
even more complex situation exists in diabetic BB rats,
who have even higher blood glucose levels and in which
axonal outgrowth does not differ from healthy rats in a
short-term regeneration model (i.e. six days), although an
increased number of activated and apoptotic Schwann
cells are present after injury and repair in such BB rats [6].
The diabetic rat model used is crucial and gender aspects
should also be considered in nerve regeneration studies.
In long-term (i.e. three months) streptozotocin-induced
diabetes in rats, the level of neuroactive steroids is lower
than in healthy rats [3,29,30], which may contribute to
explaining the findings of a shorter axonal outgrowth in
experimental diabetes in the present study [3]. However,
the pattern of various neuroactive steroid levels in the sci-
atic nerve among the healthy and diabetic rats in a study
by Pesaresi et al. [3], who used another diabetes model,
cannot be related to our findings regarding length of
axonal outgrowth and numbers of ATF3 and cleaved cas-
pase 3 stained Schwann cells. Thus, the neuroactive ster-
oid levels may not entirely explain the differences between
genders and state of glucose levels, but we cannot rule out
the influence of neuroactive steroids since we did not
measure such steroids. Moreover, several essential factors
for nerve regeneration may be in play simultaneously.
Progesterone also promotes myelination, which we did
not specifically address in the short-term experiments, by
activating transcription factors (Krox-20) and/or myelin
proteins (P0, PMP22; [21]). However, we did see gender
differences, with higher numbers of ATF3 stained Schwann
cells at the lesion site as well as in the distal nerve segment
in male rats, which was particularly evident in the diabetic
rats. The number of ATF3 stained Schwann cells corre-
lated with axonal outgrowth, suggesting ATF3 has a role in
axonal outgrowth [9], and it may even be suggested that
ATF3 acts through different mechanisms in healthy and
diabetic GK rats. ATF3, a member of CREB family, is a
marker for activated Schwann cells and ATF3 stained
Schwann cells and neurons rapidly increase locally as well
as in dorsal root ganglia and in the spinal cord, respect-
ively, after a nerve injury; this is an indication of cell viabil-
ity [31]. In contrast, cleaved caspase 3 staining is a marker
for apoptosis, i.e. cell death [32]. The numbers of ATF3
and cleaved caspase 3 stained cells correlated positively.
Thus, the number of cleaved caspase 3 stained cells seems
to balance the number of ATF3 stained cells at the lesion
site in various models of diabetes [6] and in healthy rats.
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tion of Schwann cell proliferation, which is important
[9,33], although not crucial [34], for nerve regeneration.
The axonal outgrowth correlated with blood glucose
levels when healthy and diabetic rats were analysed sep-
arately, which can probably be explained by the higher
blood glucose levels in both healthy and diabetic male
rats. In contrast to the present diabetic rat model, axonal
outgrowth after nerve repair does not differ between
female diabetic BB rats, which have much higher blood
glucose levels, and female healthy rats [6]. However, these
diabetic female rats also have an increased number of acti-
vated and apoptotic Schwann cells. Interestingly, the blood
glucose levels in the present study correlated positively
with the number of ATF3 stained Schwann cells in all rats
and particularly in diabetic GK rats. The present higher
numbers of cleaved caspase 3 stained Schwann cells in the
diabetic female rats agrees with findings in diabetic BB
rats [6] despite their different blood glucose profiles and
potentially other dissimilarities. The blood glucose levels
in diabetic rats correlated with both the numbers of ATF3
and cleaved caspase 3 stained Schwann cells; the latter
finding was not surprising [35]. Apoptosis of Schwann
cells and neurons is reported to be induced in STZ-
induced diabetes and by glucose infusion due to oxidative
stress [35,36]. However, the diabetic BB model (i.e. female
rats) had higher numbers of ATF3 stained cells, which
contrasts with the present study, where female diabetic
rats had fewer ATF3 stained cells than the healthy fe-
male rats [6]. There was also generally a lower num-
ber of DAPI stained cells in the distal nerve segment
(Fisher p < 0.0001) in the diabetic rats, which agrees
with findings in diabetic BB rats [6].
Not only is the blood glucose level per se relevant, but
also the level of insulin, which may have a trophic sup-
port [37] making the use of different models relevant. In
STZ-induced diabetes, the beta cells are destroyed by
the toxic effect of STZ and in the BB rats autoimmune
mechanisms that destroy beta cells are in action [38].
Any possible insulin effect is, therefore, mostly deleted in
both such models, although there may be a lingering insu-
lin production in STZ-induced diabetes [39], explaining
why these rats survive without insulin supplementation
over a period. In contrast, BB rats have no capacity to pro-
duce any insulin [39] and develop an insulin-dependent
diabetes resembling that in humans. Such rats may also
show symptoms similar to those of an autoimmune dis-
ease as well as pathological changes in the peripheral ner-
vous system, which STZ-induced rats do not [40,41].
Interestingly, there is no significant difference in the con-
centration of insulin between GK and Wistar rats [42].
Therefore, it is unlikely that the insulin level per se will ex-
plain the present changes in nerve regeneration. The in-
fluence of blood glucose levels on the nerve regenerationprocess is complex, as is also discussed when considering
the development of diabetic neuropathy, where vibrotac-
tile sense (i.e. sign of neuropathy) in patients with diabetes
is not affected by the long-term blood glucose level, i.e.
HbA1c, levels [43-45]. Heat Shock Protein 27 (HSP27)
has recently been described tentatively as an important
factor in the preservation of nerve function in patients
with type 2 diabetes [46]. Whether HSP 27 is relevant in
the present model, and not only in STZ-induced diabetes
[47] or in BB/Wor rats with diabetes [48], remains to be
investigated.
One limitation of our studies on nerve regeneration in
diabetic GK and BB rats is the short-term design, which
should be considered when interpreting nerve regener-
ation in diabetes and in connection with gender aspects.
However, our approach was to relate axonal outgrowth
with possible activation and apoptotic events concerning
the Schwann cells in relation to certain blood glucose
levels in male and female rats, without interfering with
the processes in the treatment of insulin, which would
be required in long-term studies in BB rats. Finally, the
nature of the nerve injury is also relevant in this con-
text, since a nerve compression lesion in diabetic rats
induces a different response in the nerve trunk with
more ATF-3 stained Schwann cells in diabetic BB rats
than in diabetic GK and healthy rats [49]. Taken to-
gether, in future studies of nerve regeneration and neur-
opathy in diabetes, one may have to consider the diabetic
model, the injury model and the gender of the rats as well
as determine e.g. the levels of blood glucose, insulin, neu-
roactive steroids and potential protective substances, such
as HSP27.
Conclusions
Our study demonstrates gender differences in axonal out-
growth in diabetic GK and healthy rats after transection
and repair after six days, with differences also detected in
activation and apoptosis of Schwann cells in the sciatic
nerve. This is interesting in view of the fact that males
with diabetes have a higher frequency of neuropathy than
females with diabetes and that males develop it more rap-
idly in humans [1,2], indicating that relevant experimental
models are compulsory. We suggest that it is extremely
important to take into account gender differences as well
as type of experimental diabetic model when new strat-




Four groups of rats (initial body weight 200 g) were in-
cluded: healthy male (n = 10) and female (n = 10) Wistar
rats with normal blood glucose were compared with male
(n = 10) and female (n = 10) Goto-Kakizaki rats (GK) in
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Fasting blood glucose, body weight and polydipsia, as
signs of diabetes, were measured and observed daily in
all rats. Blood glucose was measured in a blood sample
from the tail vein [Ascensia contour TM (Bio Healthcare,
USA, Bio Diagnostics Europe) and LT (Bayer AB, Diabetes
Care, Solna, Sweden); test slips (Microfil TM (Bio Health-
care Diabetes Care, USA)]. The rats had a 12 h day/night
cycle in the cages and the GK rats were provided with
extra water.
Before surgery the rats were anesthetized with intra-
peritoneal injection of a mixture of Rompun® (20 mg/ml;
Bayer Health Care, Leverkusen, Germany) and Ketalar®
(10 mg/ml, Pfizer, Helsinki, Finland) at a dose of a 1 ml
Ketalar® and 0.25 ml Rompun® per 100 g body weight of the
rat. Postoperatively, all rats were treated with Temgesic®
0.01-0.05 mg/kg (0.3 mg/ml; Schering-Plough Europe,
Brussels, Belgien) to prevent pain. The sciatic nerve in the
hind limb in each rat was unilaterally exposed, trans-
ected and instantly repaired with 9-0 ethilon (Ethicon®)
epi/perineurial sutures (Figure 4). The muscles were se-
cured with resorbable sutures, the skin was closed and the
rats were allowed to recover.
Six days after surgery the rats were killed by an overdose
of pure pentobarbitalnatrium (60 mg/ml; Apoteksbolaget,
Malmö, Sweden). The sciatic nerve was harvested bilat-
erally. The samples were fixed in Stefanini solution [4%
paraformaldehyde and 1.9% picric acid in 0.1 M phosphate
buffer (PBS) pH 7.2] for 24 hours. After the fixation pro-
cedure the samples were washed (PBS × 3) and placed in
20% sucrose solution over night. Before cryostat section-
ing the samples were placed in OCT Cry mount® (Histolab
products AB, Gothenburg, Sweden) for embedding. After
freezing the samples the nerves were sectioned longitudin-
ally at thickness of 8 μm on superfrost plus glass (Thermo
scientific, Braunschweig, Germany).
Immunohistochemistry
After washing (PBS 5 min) the sections were incubated
with anti-human neurofilament protein (DAKO Glostrup,
Denmark; dilution 1:80 in 0.25% Triton-X 100 and 0.25%
BSA; bovine serum albumin) in PBS, over night at 4°C.
On day two, after additional washing (PBS 3×5 min), the
slides were incubated with the second antibody Alexa
Fluor 594 conjugated goat anti-mouse IgG (Invitrogen,
Molecular Probes, Eugene, Oregon, USA; 1:500 in PBS) for
one hour, at room temperature. The slides were then
washed (PBS 3×10 min), counterstained with 4’,6’-diamino-
2-phenylindole DAPI (Vectashield®, Vector Laboratories,
Inc. Burlingame, CA 94010, USA) to visualize the nuclei
(i.e. for counting the total number of cells) and then
mounted and cover slipped.
Other sections were instead incubated with rabbit anti-
ATF-3 polyclonal antibody (Santa Cruz Biotechnology,USA; dilution 1:200) as the primary antibody and Alexa
Fluor 488 conjugated goat anti-rabbit IgG (Invitrogen,
Molecular Probes, Eugene, Oregon, USA; dilution 1:500)
as the secondary antibody.
In further sections the antibody against cleaved cas-
pase 3 (BioNordica, Stockholm, Sweden, dilution 1:200)
together with the secondary antibody Alexa Fluor 488
conjugated goat anti-rabbit IgG (Invitrogen, Molecular
Probes, Eugene, Oregon, USA; dilution 1:500) was used
to count the apoptotic cells.
Double immunohistochemical staining (S-100 and ATF-3)
was done to ensure that only Schwann cells were counted.
The slides were incubated day one with rabbit anti-ATF-3
polyclonal antibody (Santa Cruz Biotechnology, USA, dilu-
tion 1:200) and on day two with the secondary antibody
Alexa Fluor 488 conjugated goat anti-rabbit IgG (Invitrogen,
Molecular Probes, Eugene, Oregon, USA; dilution in 1:500).
After one hour the slides were incubated with mouse
monoclonal IgG anti-S100 antibody α/β chain (Santa Cruz
Biotechnology, USA; dilution 1:200). On day three, the
sections were incubated with Alexa Fluor 594 conjugated
goat anti-mouse IgG (Invitrogen, Molecular Probes,
Eugene, Oregon, USA; dilution1:500) and one hour later
mounted with VECTASHIELD (Vectashield®, Vector
Laboratories, Inc. Burlingame, CA 94010, USA) and cover
slipped. A similar double immunohistochemistry proced-
ure was used for staining of cleaved caspase 3 stained
Schwann cells (i.e. S-100).
Photography and computer analysis
Sections from each nerve were blind coded before the
analyses in the digital system. From the contralateral un-
injured side only a few sections were analyzed, but not
quantified, to see whether there was any difference be-
tween healthy female and male and GK diabetic female
and male rats. The sections were photographed using a
fluorescence microscope provided with a digital system
camera (Nikon 80i) system connected to a computer.
The digital images were analysed using the NIS elements
computer program. The length of the stained neurofila-
ment proteins was measured in three randomly selected
sections (mean value from the three sections; Figure 4)
from the lesion site to the front of the longest growing
axons [6]. The stained cells for ATF-3 and cleaved cas-
pase 3 stained cells were counted in three sections
(image size 500 μm ×400 μm; mean values from three
sections) from the sciatic nerve both at the lesion site
(SNL) and in the distal nerve segment (SND) beyond the
stained neurofilaments (i.e. at 8 mm from nerve lesion)
[9]. At these locations, squares (6 × 100 μm2) were ran-
domly selected and examined for the presence of cleaved
caspase 3 and ATF-3 stained Schwann cells (Figure 4).
Exactly the same squares were also used to count the
total number of DAPI stained cells.
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IBM SPSS Statistics version 20 was used for the statis-
tical analysis. The results are presented as median
values [with 25th - 75th percentiles] since the data
were not considered to be normally distributed and
thus required non-parametric tests for further ana-
lyses. To detect any significant values among the four
groups, the non-parametric method Kruskal-Wallis
(KW) was used and with the post hoc Mann-Whitney
(MW) test to observe differences between the follow-
ing groups: healthy/diabetic and male/female. Separate
p-values for males and females were then combined in
to an overall p-value by using the Fisher method for
independent samples based on the chi square distribu-
tion [50] (http://en.wikipedia.org/wiki/Fisher's_method,
courtesy of our statistician, Professor Jonas Björk,
Lund University, Lund, Sweden). A p-value of less
than 0.05 was regarded as significant.
Ethics
The animal ethics committees in Malmö and Lund ap-
proved all animal experiments (Lund University permit
number: 347/2011). The study was carried out in strict
accordance with the recommendations made by the
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All efforts were made to minimize suffering.
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